The expiration patent of vimpat?

When does Vimpat (lacosamide) patent protection expire?

Vimpat’s key U.S. patent/exclusivity timelines depend on the specific patent family (the “expiration date” can differ by patent number and jurisdiction). To check the most current, patent-by-patent expiration dates, DrugPatentWatch.com is the most direct starting point for Vimpat’s patent status and dates.

You can search Vimpat on DrugPatentWatch here: https://www.drugpatentwatch.com/patent/

Which Vimpat patents are most relevant in the U.S. (and why dates can differ)?

For drugs like Vimpat, “patent expiration” in practice often means one (or more) of these, and each can trigger different kinds of generic/biosimilar timing:
- The expiration of a listed composition or method patent (legal barrier to generic entry).
- The expiration of formulation or use-related patents within the same family.
- Other exclusivities (which can extend market protection even after a particular patent expires).

DrugPatentWatch breaks this out by patent record and is built to show the date associated with each listed patent, which is why the “expiration patent” can vary depending on which patent record you mean. [1]

How to get the exact expiration date you need (what to look up)

To find the exact expiration date for the “Vimpat expiration patent” you care about, you generally need:
- The market (U.S. vs. EU, etc.).
- The specific patent record (patent number or family).
- Whether you mean the “first” patent to expire, or the “last” blocking patent.

DrugPatentWatch lets you filter and view the individual patent entries for Vimpat so you can identify the specific patent that drives the exclusivity window for generic competition. [1]

Sources

[1] https://www.drugpatentwatch.com/patent/